WoS SCIE & CAS Academic Rankings
Global Journal Rankings & Directory
Explore academic hierarchies, Clarivate Impact Factors, Web of Science Q1–Q4 quartiles, and CAS divisions.
Showing 76–100 of 232 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Impact Factor | H-Index | WoS Quartile | Scopus SJR | CAS Division | Self-Citation | Docs/yr | Publisher |
|---|---|---|---|---|---|---|---|---|---|
| #76 | JTO Clinical and Research Reports ISSN: 2666-3643 | 3.6 | 31 | Q2 | 1.708Q1 | CAS Tier 2 | 3.3% | 108 | Elsevier |
| #77 | Journal of Bone Oncology ISSN: 2212-1366 / 2212-1374 | 3.6 | 46 | Q2 | 1.087Q2 | CAS Tier 3 | 3.2% | 62 | Elsevier GmbH |
| #78 | Journal of Breast Cancer ISSN: 1738-6756 | 3.6 | 55 | Q2 | 0.89Q2 | CAS Tier 4 | 4.5% | 52 | Korean Breast Cancer Society |
| #79 | Precision Radiation Oncology ISSN: 2398-7324 | 3.6 | 14 | Q1 | 0.746Q2 | CAS Tier 4 | N/A | 41 | Wiley |
| #80 | Radiation Oncology ISSN: 1748-717X | 3.6 | 102 | Q2 | 1.05Q1 | CAS Tier 2 | 6.1% | 236 | BioMed Central |
| #81 | World Journal of Clinical Oncology ISSN: 2218-4333 | 3.6 | — | Q2 | — | CAS Tier 3 | 0% | 89 | Baishideng Publishing Group |
| #82 | Cancer Medicine ISSN: 2045-7634 | 3.5 | 105 | Q2 | 1.156Q1 | CAS Tier 3 | 3.4% | 772 | John Wiley and Sons Ltd |
| #83 | Cancer Treatment and Research Communications ISSN: 2468-2942 | 3.5 | 35 | Q2 | 0.995Q2 | CAS Tier 4 | N/A | 320 | Elsevier |
| #84 | Cancer Prevention Research ISSN: 1940-6207 / 1940-6215 | 3.4 | 120 | Q2 | 1.129Q1 | CAS Tier 3 | 3.4% | 102 | American Association for Cancer Research Inc. |
| #85 | Journal of Cancer ISSN: 1837-9664 | 3.4 | 99 | Q2 | 0.852Q2 | CAS Tier 3 | 0% | 710 | Ivyspring International Publisher |
| #86 | Journal of Cancer Survivorship ISSN: 1932-2259 / 1932-2267 | 3.4 | 93 | Q2 | 1.151Q1 | CAS Tier 2 | 6.5% | 155 | Springer US |
| #87 | Oncology and Therapy ISSN: 2366-1070 / 2366-1089 | 3.4 | 24 | Q2 | 1.159Q2 | CAS Tier 3 | 0% | 42 | Adis, Springer Healthcare |
| #88 | Translational Lung Cancer Research ISSN: 2218-6751 | 3.4 | 78 | Q2 | 0.987Q2 | CAS Tier 3 | 5% | 354 | Society for Translational Medicine (STM) |
| #89 | Breast Cancer Research and Treatment ISSN: 0167-6806 / 1573-7217 | 3.3 | 189 | Q2 | 1.34Q1 | CAS Tier 3 | 6.7% | 398 | Springer US |
| #90 | Journal of Cancer Research and Clinical Oncology ISSN: 0171-5216 / 1432-1335 | 3.3 | 118 | Q2 | 0.954Q1 | CAS Tier 3 | 3.7% | 362 | Springer Berlin Heidelberg |
| #91 | Lung Cancer: Targets and Therapy ISSN: 1179-2728 | 3.3 | 32 | Q2 | 1.028Q2 | CAS Tier 3 | N/A | 8 | Dove Medical Press |
| #92 | Blood and Lymphatic Cancer-Targets and Therapy ISSN: 1179-9889 | 3.2 | — | Q2 | — | CAS Tier 3 | 0% | 6 | Dove Medical Press |
| #93 | Infectious Agents and Cancer ISSN: 1750-9378 | 3.2 | 54 | Q3 | 0.92Q2 | CAS Tier 3 | 3.2% | 66 | BioMed Central |
| #94 | American Journal of Cancer Research ISSN: 2156-6976 | 3.1 | 20 | Q2 | — | CAS Tier 3 | 2.8% | 381 | E-CENTURY PUBLISHING CORP |
| #95 | Cancer Control ISSN: 1073-2748 / 1526-2359 | 3.1 | 88 | Q2 | 0.907Q1 | CAS Tier 3 | 4% | 133 | H. Lee Moffitt Cancer Center and Research Institute |
| #96 | Future Oncology ISSN: 1479-6694 / 1744-8301 | 3.1 | 102 | Q2 | 1.229Q1 | CAS Tier 4 | 3.3% | 390 | Future Medicine Ltd. |
| #97 | Journal of Immunotherapy and Precision Oncology ISSN: 2666-2345 / 2590-017X | 3.1 | 15 | Q3 | 1.37Q1 | CAS Tier 4 | N/A | 6 | Innovative Healthcare Institute |
| #98 | Cancer Epidemiology ISSN: 1877-7821 / 1877-783X | 3 | 94 | Q3 | 1.036Q2 | CAS Tier 3 | 4.2% | 144 | Elsevier BV |
| #99 | Expert Review of Anticancer Therapy ISSN: 1473-7140 / 1744-8328 | 3 | 91 | Q3 | 0.84Q2 | CAS Tier 3 | 0% | 99 | Taylor and Francis Ltd. |
| #100 | International Journal of Clinical Oncology ISSN: 1341-9625 / 1437-7772 | 3 | 83 | Q3 | 0.945Q1 | CAS Tier 3 | 0% | 239 | Springer Singapore |